Don't forget about Novavax (NASDAQ:NVAX). It could be easy for investors to do so. The company's COVID-19 vaccine still isn't authorized in any major market. Its shares are more than 30% below the ...
网页链接Don't forget about Novavax (NASDAQ:NVAX). It could be easy for investors to do so. The company's COVID-19 vaccine still isn't authorized in any major market. Its shares are more than 30% below the ...
网页链接
精彩评论